• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17385

【品名】(9aS,12S,13R,14S,17R,21S,23S,24R,25S,27R)-17-allyl-24-[[tert-butyl(dimethyl)silyl]oxy]-12-[(E)-2-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethenyl]-14-hydroxy-23,25-dimethoxy-2,2,13,19,21,27-hexamethyl-7,8,9,9a,12,13,14,15,20,21,22,23,24,25,26,27-hexadecahydro-4H-[1,3]dioxolo[4,5-f]pyrido[2,1-c][1,4]oxazacyclotricosine-4,10,16(6H,17H)-trione

【CA登记号】

【 分 子 式 】C69H107NO12Si2

【 分 子 量 】1198.77912

【元素组成】C 69.13% H 9% N 1.17% O 16.02% Si 4.69%

与该中间体有关的原料药合成路线共 2 条

合成路线1

该中间体在本合成路线中的序号:(XVII)

Ester (XIII) was submitted to cyclization by means of triethylsilyl triflate and 2-chloro-1-methylpyridinium iodide (MCPI) in dichloromethane/methanol gaving the macrocyclic compound (XIV). Elimination of the p-methoxybenzyl group of (XIV) with dichlorodicyanobenzoquinone (DDQ) in dichloromethane yielded the alcohol (XV), which was converted into the iodo derivative (XVI) with I2, triphenylphosphine and imidazole in hot toluene. The reductive fragmentation of the spiroketal rings of (XVI) with zinc/silver-graphite in THF afforded compound (XVII) with the adequate configuration in the C21-C24 fragment.

1 Liu, L.B.; Roper, T.D.; Gleason, J.L.; Ireland, R.E.; Total synthesis of FK-506. 2. Completion of the synthesis. Tetrahedron 1997, 53, 39, 13257.
2 Liu, L.B.; Roper, T.D.; Ireland, R.E.; Total synthesis of FK-506. 1. Construction of the C16-C34 fragment. Tetrahedron 1997, 53, 39, 13221.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIII) 17381 5-((1R,3S,4R,5S,7S,9E)-4-[[tert-butyl(dimethyl)silyl]oxy]-10-[4-((1R,2S,3E)-4-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1,3-dimethyl-2-[[(2S)piperidinylcarbonyl]oxy]-3-butenyl)-9-[(4-methoxybenzyl)oxy]-2,2-dimethyl-1,3,7-trioxaspiro[5.5]undec-11-yl]-3,5-dimethoxy-1,7,9-trimethyl-9-decenyl)-2,2-dimethyl-1,3-dioxole-4-carboxylic acid C80H123NO16Si2 详情 详情
(XIV) 17382 (10S,12S,13R,14S,16R,28S,31S,32R)-13-[[tert-butyl(dimethyl)silyl]oxy]-31-[(E)-2-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethenyl]-12,14-dimethoxy-4-[(4-methoxybenzyl)oxy]-8,10,16,19,19,32,35,35-octamethyl-2,18,20,30,34,36-hexaoxa-23-azapentacyclo[31.3.1.0(1,6).0(17,21).0(23,28)]heptatriaconta-7,17(21)-diene-22,29-dione C80H121NO15Si2 详情 详情
(XV) 17383 (10S,12S,13R,14S,16R,28S,31S,32R)-13-[[tert-butyl(dimethyl)silyl]oxy]-31-[(E)-2-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethenyl]-4-hydroxy-12,14-dimethoxy-8,10,16,19,19,32,35,35-octamethyl-2,18,20,30,34,36-hexaoxa-23-azapentacyclo[31.3.1.0(1,6).0(17,21).0(23,28)]heptatriaconta-7,17(21)-diene-22,29-dione C72H113NO14Si2 详情 详情
(XVI) 17384 (10S,12S,13R,14S,16R,28S,31S,32R)-13-[[tert-butyl(dimethyl)silyl]oxy]-31-[(E)-2-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethenyl]-4-iodo-12,14-dimethoxy-8,10,16,19,19,32,35,35-octamethyl-2,18,20,30,34,36-hexaoxa-23-azapentacyclo[31.3.1.0(1,6).0(17,21).0(23,28)]heptatriaconta-7,17(21)-diene-22,29-dione C72H112INO13Si2 详情 详情
(XVII) 17385 (9aS,12S,13R,14S,17R,21S,23S,24R,25S,27R)-17-allyl-24-[[tert-butyl(dimethyl)silyl]oxy]-12-[(E)-2-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethenyl]-14-hydroxy-23,25-dimethoxy-2,2,13,19,21,27-hexamethyl-7,8,9,9a,12,13,14,15,20,21,22,23,24,25,26,27-hexadecahydro-4H-[1,3]dioxolo[4,5-f]pyrido[2,1-c][1,4]oxazacyclotricosine-4,10,16(6H,17H)-trione C69H107NO12Si2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XVII)

The 1,3-dioxole ring of (XVII) was cleaved by selective oxidation with dimethyldioxirane (DMD) in acetone giving the tricarbonyl compound (XVIII) (silylated FK-506), which was finally desilylated by means of HF in acetonitrile/ water. 2) Aldehyde (VI) was prepared according to a previously reported method (Ireland, R.E. et al. J Org Chem 1992, 57: 5071).

1 Liu, L.B.; Roper, T.D.; Ireland, R.E.; Total synthesis of FK-506. 1. Construction of the C16-C34 fragment. Tetrahedron 1997, 53, 39, 13221.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XVII) 17385 (9aS,12S,13R,14S,17R,21S,23S,24R,25S,27R)-17-allyl-24-[[tert-butyl(dimethyl)silyl]oxy]-12-[(E)-2-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethenyl]-14-hydroxy-23,25-dimethoxy-2,2,13,19,21,27-hexamethyl-7,8,9,9a,12,13,14,15,20,21,22,23,24,25,26,27-hexadecahydro-4H-[1,3]dioxolo[4,5-f]pyrido[2,1-c][1,4]oxazacyclotricosine-4,10,16(6H,17H)-trione C69H107NO12Si2 详情 详情
(XVIII) 17386 (3S,4R,5S,8R,12S,14S,15R,16S,18R,26aS)-8-allyl-15-[[tert-butyl(dimethyl)silyl]oxy]-3-[(E)-2-((1R,3R,4R)-4-[[tert-butyl(diphenyl)silyl]oxy]-3-methoxycyclohexyl)-1-methylethenyl]-5-hydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-3H-pyrido[2,1-c][1,4]oxazacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentone C66H101NO12Si2 详情 详情
Extended Information